OXACELL

The name OXACELL® is derived from axolotl (Ambystoma mexicanum), an aquatic living Mexican salamander with the astonishing ability of self-healing. Axolotl can activate stem cells to regenerate entire extremities and organs. We, as an innovative biopharmaceutical company, take the axolotl as a role model. Hence, we develop advanced therapy medicinal products (ATMPs) on the basis of human stem cells... At OXACELL®, we develop state-of-the-art therapies and medicinal products on the basis of adipose-derived mesenchymal stem cells. The high content of potent stem cells and the low risk during harvesting renders adipose tissue an ideal source of stem cells.

Also known as: Oxacell AG, The OXACELL® AG

Primary location: Potsdam Chile